-
Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline | DelveInsight
20 Jun 2025 00:25 GMT
… , MacroGenics, Inc., RayzeBio, Inc., Genentech, Eli Lilly and Company, Amgen, Hutchison Medipharma Limited, Biocity …
DelveInsight is a leading Business Consultant and Market Research firm focused …
-
Global Protein Expression Market to Observe Growth at a CAGR of ~8% by 2032 | DelveInsight
19 Jun 2025 17:00 GMT
… Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Novartis AG … DelveInsight is a leading Business Consultant, and Market Research firm focused …
-
Dermatomyositis Market Set to Witness Significant Growth During the Study Period (2020–2034) Amid Rising Awareness and Advanced Treatments | DelveInsight
19 Jun 2025 17:00 GMT
… , Horizon Therapeutics, Immunoforge, Restem, LLC., Eli Lilly and Company, among others. Polymyositis Pipeline Polymyositis … DelveInsight is a leading Business Consultant and Market Research firm focused …
-
Rimegepant superior to placebo in patients with migraine unresponsive to triptans
19 Jun 2025 19:47 GMT
Add topic to email alerts
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Key takeaways:
Rimegepant offered superior sustained pain …
-
Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight
18 Jun 2025 17:00 GMT
… ., Eledon Pharmaceuticals, Eli Lilly and Company, Novo Nordisk A … companies, including Eli Lilly and Company, Regor Pharmaceuticals … Tonghua Dongbao Pharmaceutical, Eli Lilly and Company, Rivus Pharmaceuticals, … leading Business Consultant, and Market …
-
Geriatric Medicines Market Growing Elderly Population and Advancements in Specialized Drug Development Poised to Drive Market Expansion to USD 1,701.91 Billion by 2032
18 Jun 2025 14:04 GMT
… in geriatric medicines market report:
Eli Lilly and Company
Takeda Pharmaceutical Company Limited
Pfizer … scope and have 450+ seasoned consultants, analysts, and researchers across 26 …
-
Trastuzumab deruxtecan plus pertuzumab ‘nearly doubles’ disease control in breast cancer
19 Jun 2025 01:56 GMT
Add topic to email alerts
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Key takeaways:
Trastuzumab deruxtecan plus pertuzumab …
-
Radiopharmaceuticals Market Size Expected to Surpass $21.8 Billion by 2033 with 10.6% CAGR From 2023-2033
18 Jun 2025 10:25 GMT
… AG
Cardinal Health
Curium Pharma
Eli Lilly and Company
Jubilant Pharmova Limited
Lantheus
ITM … meet the needs of SME consultants and industry leaders. Moreover, our … large network of skilled consultants and experts help start-ups …
-
Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
17 Jun 2025 17:00 GMT
… Therapeutics, Janssen Research & Development, Eli Lilly and Company, Arrowhead Pharmaceuticals, Sylentis, Sirnaomics, Dicerna … DelveInsight is a leading Business Consultant and Market Research firm focused …
-
Interleukin Inhibitors Market worth USD 85.51 billion by 2032 - Exclusive Report by Coherent Market Insights
17 Jun 2025 13:07 GMT
… :
Johnson & Johnson
AbbVie Inc.
Eli Lilly and Company
Amgen Inc.
Sanofi S.A … scope and have 450+ seasoned consultants, analysts, and researchers across 26 …
About
© 1995-2025